FDA
Tofacitinib Citrate
The FDA lists this product in 31 strengths and forms.
Composition
- Active ingredients
- TOFACITINIB CITRATE EQ 10MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TOFACITINIB CITRATE EQ 22MG BASE · Tablet, extended releaseANDA214264-002 · Prescription
- TOFACITINIB CITRATE EQ 11MG BASE · Tablet, extended releaseANDA214264-001 · Prescription
- TOFACITINIB CITRATE EQ 5MG BASE · TabletANDA215356-001 · Prescription
- TOFACITINIB CITRATE EQ 10MG BASE · TabletANDA215356-002 · Prescription
- TOFACITINIB CITRATE EQ 1MG BASE/ML · SolutionANDA218407-001 · Prescription
- TOFACITINIB CITRATE EQ 10MG BASE · TabletANDA218096-002 · Prescription
- TOFACITINIB CITRATE EQ 5MG BASE · TabletANDA218096-001 · Prescription
- TOFACITINIB CITRATE EQ 11MG BASE · Tablet, extended releaseANDA218462-001 · Prescription
- TOFACITINIB CITRATE EQ 1MG BASE/ML · SolutionANDA216878-001 · Prescription
- TOFACITINIB CITRATE EQ 5MG BASE · TabletANDA217299-001 · Prescription
- TOFACITINIB CITRATE EQ 10MG BASE · TabletANDA217299-002 · Prescription
At a glance
- Brand name
- Tofacitinib Citrate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Ajanta Pharma LTD
- Status
- Prescription
- FDA approval
- 1 Jun 2021
- Application
- ANDA212943-001